{"hands_on_practices": [{"introduction": "Before undertaking a major liver resection, the surgeon's primary responsibility is to ensure the patient will have enough functional liver remaining to prevent postoperative organ failure. This practice centers on the crucial calculation of the future liver remnant (FLR) fraction from volumetric imaging data, a key predictor of outcomes. Mastering this calculation and understanding the established safety thresholds that guide interventions like portal vein embolization (PVE) is a non-negotiable skill for ensuring patient safety in complex hepatobiliary surgery [@problem_id:4611965].", "problem": "A patient with colorectal liver metastases is planned for a major hepatectomy after neoadjuvant cytotoxic chemotherapy. The total functional liver volume (TFLV) measured by three-dimensional volumetry is $1400$ $\\mathrm{mL}$, and the estimated future liver remnant (FLR) is $360$ $\\mathrm{mL}$. Using the fundamental definition that the FLR fraction is the ratio of the remnant volume to the total functional liver volume, and the well-established safety principle that chemotherapy-associated liver injury raises the minimal acceptable FLR fraction for major hepatectomy, determine the FLR fraction and whether preoperative Portal Vein Embolization (PVE) is indicated for a chemotherapy-exposed patient.\n\nFor decision-making, adopt the widely accepted thresholds that a minimal FLR fraction of at least $0.20$ is adequate for a physiologically normal liver, at least $0.30$ for a chemotherapy-exposed liver, and at least $0.40$ for a liver with chronic disease (for example, cirrhosis). PVE is indicated when the calculated FLR fraction is below the applicable threshold.\n\nAnswer specification:\n- Express the FLR fraction as an exact rational number (do not use a percentage sign).\n- Encode the PVE decision as $D$, where $D=1$ if PVE is indicated and $D=0$ otherwise.\n- Provide the final answer as a row matrix $\\big($FLR fraction, $D\\big)$ using the LaTeX pmatrix environment.", "solution": "The goal is to compute the future liver remnant fraction using first principles and then apply well-tested clinical thresholds to decide on Portal Vein Embolization (PVE).\n\nFundamental base:\n1. The FLR fraction, by definition, is the ratio of the future liver remnant (FLR) volume to the total functional liver volume (TFLV). In symbols,\n$$\n\\text{FLR fraction} = \\frac{\\text{FLR volume}}{\\text{TFLV}}.\n$$\n2. Chemotherapy-associated liver injury (for example, sinusoidal obstruction syndrome and chemotherapy-associated steatohepatitis) increases the minimal safe FLR fraction required for major hepatectomy. Widely accepted thresholds are:\n   - Normal liver: at least $0.20$.\n   - Chemotherapy-exposed liver: at least $0.30$.\n   - Chronic liver disease: at least $0.40$.\n3. Portal Vein Embolization (PVE) is indicated when the calculated FLR fraction is below the relevant threshold for the patient’s liver status.\n\nStep 1: Compute the FLR fraction from the given volumes.\nGiven TFLV $=1400$ $\\mathrm{mL}$ and FLR volume $=360$ $\\mathrm{mL}$,\n$$\n\\text{FLR fraction} = \\frac{360}{1400}.\n$$\nReduce the fraction to lowest terms:\n$$\n\\frac{360}{1400} = \\frac{36}{140} = \\frac{18}{70} = \\frac{9}{35}.\n$$\nThus, the exact FLR fraction is\n$$\n\\frac{9}{35}.\n$$\n\nStep 2: Determine whether PVE is indicated for a chemotherapy-exposed patient.\nFor chemotherapy-exposed livers, the minimal acceptable FLR fraction is at least $0.30$. We compare $\\frac{9}{35}$ to $0.30$.\n\nCompute or estimate:\n$$\n\\frac{9}{35} = 0.257142\\ldots\n$$\nSince $0.257142\\ldots < 0.30$, the FLR fraction is below the chemotherapy-exposed threshold. Therefore, PVE is indicated.\n\nStep 3: Encode the decision.\nLet $D=1$ if PVE is indicated and $D=0$ otherwise. From Step 2, $D=1$.\n\nFinal composition:\nProvide the final answer as a row matrix $(\\text{FLR fraction}, D)$:\n$$\n\\begin{pmatrix}\n\\frac{9}{35} & 1\n\\end{pmatrix}.\n$$", "answer": "$$\\boxed{\\begin{pmatrix}\\frac{9}{35} & 1\\end{pmatrix}}$$", "id": "4611965"}, {"introduction": "Once a hepatic resection is deemed technically and physiologically feasible, the focus shifts to quantifying the patient's oncologic risk to guide counseling and multimodal therapy. This exercise involves the application of the Fong Clinical Risk Score, a simple yet powerful and validated prognostic tool that uses five preoperative variables to stratify patients based on their likelihood of disease recurrence. Calculating this score is a fundamental part of the preoperative workup, helping to set realistic expectations and inform shared decision-making regarding the role of systemic therapies [@problem_id:4611983].", "problem": "A surgical oncology team is planning hepatic resection for a patient with colorectal liver metastases. A preoperative clinical risk stratification using the Fong Clinical Risk Score is required. The Fong Clinical Risk Score is constructed as the sum of five binary indicators, each contributing one point when present, based on well-validated adverse prognostic features assessed before resection. The features are: node-positive primary colorectal cancer, disease-free interval (DFI) less than $12$ months from treatment of the primary tumor to diagnosis of liver metastases, more than $1$ hepatic metastasis, largest hepatic metastasis diameter greater than $5$ cm, and preoperative carcinoembryonic antigen (CEA) concentration greater than $200$ ng/mL.\n\nA $58$-year-old with resected colon adenocarcinoma had node-positive disease at the time of primary resection. The disease-free interval to detection of liver metastases was $8$ months. Preoperative imaging shows $3$ hepatic lesions, with the largest measuring $6$ cm in maximal diameter. The preoperative carcinoembryonic antigen (CEA) is $220$ ng/mL.\n\nUsing the above definitions, calculate the patient’s Fong Clinical Risk Score as a pure number. No units are required. No rounding is necessary.", "solution": "The problem as stated is scientifically grounded, well-posed, objective, and contains all necessary information for its resolution. It accurately describes the Fong Clinical Risk Score, a validated prognostic tool in surgical oncology. The provided patient data is clinically realistic and allows for a direct calculation. Therefore, the problem is deemed valid.\n\nThe task is to calculate the Fong Clinical Risk Score for a given patient. The score is defined as the sum of points from five binary prognostic indicators. A score of $1$ is assigned for each indicator that is present, and a score of $0$ is assigned for each that is absent.\n\nLet us evaluate each of the five criteria based on the patient's data provided in the problem statement.\n\n1.  **Node-positive primary colorectal cancer:** The problem states that the patient had \"node-positive disease at the time of primary resection.\" This criterion is therefore present.\n    Points for this criterion = $1$.\n\n2.  **Disease-free interval (DFI) less than $12$ months:** The problem specifies that the DFI from treatment of the primary tumor to the diagnosis of liver metastases was $8$ months. Since $8 < 12$, this criterion is met.\n    Points for this criterion = $1$.\n\n3.  **More than $1$ hepatic metastasis:** The preoperative imaging reveals \"$3$ hepatic lesions.\" Since $3 > 1$, this criterion is met.\n    Points for this criterion = $1$.\n\n4.  **Largest hepatic metastasis diameter greater than $5$ cm:** The problem states that the largest lesion measures \"$6$ cm in maximal diameter.\" Since $6 > 5$, this criterion is met.\n    Points for this criterion = $1$.\n\n5.  **Preoperative carcinoembryonic antigen (CEA) concentration greater than $200$ ng/mL:** The patient's preoperative CEA level is given as \"$220$ ng/mL.\" Since $220 > 200$, this criterion is met.\n    Points for this criterion = $1$.\n\nThe total Fong Clinical Risk Score is the summation of the points from each of the five criteria.\nLet $S$ be the total score.\n$$S = (\\text{Points for criterion } 1) + (\\text{Points for criterion } 2) + (\\text{Points for criterion } 3) + (\\text{Points for criterion } 4) + (\\text{Points for criterion } 5)$$\n$$S = 1 + 1 + 1 + 1 + 1$$\n$$S = 5$$\n\nThe patient presents with all five adverse prognostic features, resulting in the maximum possible risk score.", "answer": "$$\\boxed{5}$$", "id": "4611983"}, {"introduction": "Vigilant postoperative management is critical following major hepatectomy, as post-hepatectomy liver failure (PHLF) remains the most feared and life-threatening complication. This practice challenges the learner to apply the rigorous International Study Group of Liver Surgery (ISGLS) criteria to diagnose and grade the severity of PHLF in various clinical scenarios. Prompt and accurate classification of PHLF based on specific laboratory values and clinical support needs is essential for initiating appropriate, grade-specific management and communicating effectively within the multidisciplinary care team [@problem_id:4611957].", "problem": "A $62$-year-old individual underwent right hepatectomy for colorectal liver metastases. Preoperative laboratory values were international normalized ratio (INR) $1.0$ and total bilirubin $0.7$ mg/dL. Post-hepatectomy liver failure (PHLF) is to be classified according to the International Study Group of Liver Surgery (ISGLS) framework, which bases diagnosis on deterioration of hepatic synthetic and excretory function assessed by INR and bilirubin on or after postoperative day $5$, and grades severity according to the degree of deviation from routine postoperative management, including whether invasive support is required. Five postoperative scenarios are presented:\n\n- Scenario $1$: On postoperative day $5$, INR $1.7$, total bilirubin $2.8$ mg/dL. The patient remains on room air, mobilizing, and requires no deviation from routine postoperative orders.\n- Scenario $2$: On postoperative day $6$, INR $1.6$, total bilirubin $3.1$ mg/dL. The patient requires intravenous albumin, diuretics, and oxygen via nasal cannula but no invasive procedures.\n- Scenario $3$: On postoperative day $3$, INR $1.8$, total bilirubin $3.2$ mg/dL. The patient requires vasopressor support and is monitored in the Intensive Care Unit (ICU).\n- Scenario $4$: On postoperative day $7$, INR $1.1$, total bilirubin $4.5$ mg/dL. The patient is mildly jaundiced, receives oral ursodiol, and otherwise follows routine orders without hemodynamic support.\n- Scenario $5$: On postoperative day $7$, INR $2.4$, total bilirubin $5.2$ mg/dL. The patient develops encephalopathy, is intubated for airway protection, and undergoes continuous renal replacement therapy.\n\nWhich options correctly define the presence of post-hepatectomy liver failure and its ISGLS severity grade in each scenario?\n\nA. Scenario $1$ represents ISGLS post-hepatectomy liver failure, Grade A.\n\nB. Scenario $2$ represents ISGLS post-hepatectomy liver failure, Grade B.\n\nC. Scenario $3$ represents ISGLS post-hepatectomy liver failure, Grade C.\n\nD. Scenario $4$ represents ISGLS post-hepatectomy liver failure, Grade B.\n\nE. Scenario $5$ represents ISGLS post-hepatectomy liver failure, Grade C.\n\nSelect all that apply.", "solution": "The problem statement will be validated before a solution is attempted.\n\n### Step 1: Extract Givens\n- Patient age: $62$ years\n- Procedure: Right hepatectomy for colorectal liver metastases\n- Preoperative laboratory values: International normalized ratio (INR) $1.0$, total bilirubin $0.7$ mg/dL\n- Framework for classification: International Study Group of Liver Surgery (ISGLS) for post-hepatectomy liver failure (PHLF)\n- ISGLS diagnostic criteria: Deterioration of hepatic function assessed by INR and total bilirubin on or after postoperative day (POD) $5$.\n- ISGLS severity grading: Based on deviation from routine postoperative management and the requirement for invasive support.\n- Scenario $1$: On POD $5$, INR is $1.7$ and total bilirubin is $2.8$ mg/dL. No deviation from routine management.\n- Scenario $2$: On POD $6$, INR is $1.6$ and total bilirubin is $3.1$ mg/dL. Requires intravenous albumin, diuretics, and oxygen via nasal cannula; no invasive procedures.\n- Scenario $3$: On POD $3$, INR is $1.8$ and total bilirubin is $3.2$ mg/dL. Requires vasopressor support and Intensive Care Unit (ICU) monitoring.\n- Scenario $4$: On POD $7$, INR is $1.1$ and total bilirubin is $4.5$ mg/dL. Mild jaundice, receives oral ursodiol, routine orders otherwise.\n- Scenario $5$: On POD $7$, INR is $2.4$ and total bilirubin is $5.2$ mg/dL. Patient develops encephalopathy, is intubated, and undergoes continuous renal replacement therapy.\n\n### Step 2: Validate Using Extracted Givens\nThe problem describes a clinical situation and asks for the application of a standard, internationally recognized classification system (ISGLS criteria for PHLF).\n\n- **Scientifically Grounded:** The problem is based on established medical definitions and clinical practice in general surgery and hepatology. The ISGLS criteria are a cornerstone of modern liver surgery research and practice. The patient profile, surgical procedure, and postoperative scenarios are medically plausible. The problem is scientifically sound.\n- **Well-Posed:** The problem provides the necessary baseline data (preoperative labs) and the specific rules for diagnosis and grading (ISGLS framework). Each scenario presents a unique set of data points (time, labs, interventions) that can be unambiguously classified according to the provided rules. A unique solution exists.\n- **Objective:** The problem uses precise clinical terminology and quantitative data (lab values, postoperative day). The scenarios are described factually, without subjective or ambiguous language.\n- **Completeness and Consistency:** The problem provides the fundamental components of the ISGLS definition: the specific laboratory parameters (INR, bilirubin), the time frame for diagnosis (on or after POD $5$), and the basis for grading (deviation from routine care). All information required to answer the question is present and internally consistent.\n\n### Step 3: Verdict and Action\nThe problem statement is valid. It is a well-posed, scientifically grounded question that tests the application of a standard clinical classification system. A solution will now be derived.\n\n### Solution Derivation\nThe solution requires the strict application of the International Study Group of Liver Surgery (ISGLS) definition and grading system for post-hepatectomy liver failure (PHLF). The governing principles are as follows:\n\n1.  **Diagnosis of PHLF:** The diagnosis requires a postoperatively acquired deterioration in liver function, specifically characterized by an increased INR **and** a concomitant increase in serum bilirubin, measured on or after POD $5$. The patient's preoperative values of INR $1.0$ and total bilirubin $0.7$ mg/dL serve as the baseline.\n2.  **Severity Grading of PHLF:**\n    - **Grade A:** PHLF is diagnosed based on laboratory values, but it requires **no change** in the patient's routine clinical management.\n    - **Grade B:** PHLF requires a deviation from routine management, but therapy is **non-invasive**. This includes fluid administration, diuretics, electrolytes, and non-invasive clotting factor correction (e.g., fresh frozen plasma, vitamin K).\n    - **Grade C:** PHLF requires **invasive therapy**. This includes management in an ICU, vasopressor support, mechanical ventilation (intubation), dialysis or hemofiltration (e.g., continuous renal replacement therapy), and management of severe encephalopathy (Grade III/IV).\n\nEach scenario will be evaluated against these principles.\n\n### Option-by-Option Analysis\n\n**A. Scenario $1$ represents ISGLS post-hepatectomy liver failure, Grade A.**\n-   **Diagnosis:** The assessment is on POD $5$, which meets the time criterion. The INR is $1.7$ (increased from $1.0$) and total bilirubin is $2.8$ mg/dL (increased from $0.7$ mg/dL). Both laboratory criteria for PHLF are met. Therefore, PHLF is present.\n-   **Grading:** The patient \"requires no deviation from routine postoperative orders.\" This directly corresponds to the definition of Grade A PHLF.\n-   **Verdict:** **Correct**.\n\n**B. Scenario $2$ represents ISGLS post-hepatectomy liver failure, Grade B.**\n-   **Diagnosis:** The assessment is on POD $6$, which meets the time criterion (on or after POD $5$). The INR is $1.6$ (increased from $1.0$) and total bilirubin is $3.1$ mg/dL (increased from $0.7$ mg/dL). Both laboratory criteria are met. Therefore, PHLF is present.\n-   **Grading:** The patient requires \"intravenous albumin, diuretics, and oxygen via nasal cannula but no invasive procedures.\" These interventions are a deviation from routine management but are non-invasive. This corresponds to the definition of Grade B PHLF.\n-   **Verdict:** **Correct**.\n\n**C. Scenario $3$ represents ISGLS post-hepatectomy liver failure, Grade C.**\n-   **Diagnosis:** The assessment is on POD $3$. The ISGLS definition explicitly requires that the diagnostic criteria be met \"on or after postoperative day $5$\". Since the assessment time is before POD $5$, this condition does not meet the ISGLS definition of PHLF, regardless of the patient's severe clinical state. While the patient has severe early liver dysfunction, it is not classified as ISGLS PHLF.\n-   **Verdict:** **Incorrect**.\n\n**D. Scenario $4$ represents ISGLS post-hepatectomy liver failure, Grade B.**\n-   **Diagnosis:** The assessment is on POD $7$, which meets the time criterion. The total bilirubin is $4.5$ mg/dL, which is elevated. However, the INR is $1.1$. This is a minimal, clinically insignificant increase from the preoperative baseline of $1.0$. The ISGLS definition requires deterioration in *both* excretory (bilirubin) and synthetic (INR) function. An INR of $1.1$ does not represent a meaningful deterioration of synthetic capacity. Thus, the criteria for the diagnosis of PHLF are not met. The patient has postoperative jaundice, not PHLF.\n-   **Verdict:** **Incorrect**.\n\n**E. Scenario $5$ represents ISGLS post-hepatectomy liver failure, Grade C.**\n-   **Diagnosis:** The assessment is on POD $7$, which meets the time criterion. The INR is $2.4$ (increased from $1.0$) and total bilirubin is $5.2$ mg/dL (increased from $0.7$ mg/dL). Both laboratory criteria are met. Therefore, PHLF is present.\n-   **Grading:** The patient \"is intubated for airway protection\" (requiring mechanical ventilation) and \"undergoes continuous renal replacement therapy.\" Both intubation and renal replacement therapy are invasive measures. This corresponds to the definition of Grade C PHLF.\n-   **Verdict:** **Correct**.", "answer": "$$\\boxed{ABE}$$", "id": "4611957"}]}